首页 > 最新文献

Acta otorrinolaringologica espanola最新文献

英文 中文
Clinical practice guideline on the management of vestibular schwannoma 前庭分裂瘤治疗临床实践指南。
Pub Date : 2024-03-01 DOI: 10.1016/j.otoeng.2023.10.005
Luis Lassaletta , Leticia Acle Cervera , Xabier Altuna , Emilio Amilibia Cabeza , Miguel Arístegui Ruiz , Ángel Batuecas Caletrio , Jesús Benítez del Rosario , Rubén Cabanillas Farpón , María Costales Marcos , Pedro Escada , Juan Manuel Espinosa-Sánchez , Roberto García Leal , Javier Gavilán , Justo Gómez Martínez , Rocío González-Aguado , Victor Martinez-Glez , Gloria Guerra Jiménez , Alejandro Harguindey Antolí-Candela , Borja J. Hernández García , Cesar Orús Dotú , José Manuel Morales Puebla

Introduction

Vestibular schwannoma (VS) is the most common tumour of the cerebellopontine angle. The greater accessibility to radiological tests has increased its diagnosis. Taking into account the characteristics of the tumour, the symptoms and the age of the patient, three therapeutic strategies have been proposed: observation, surgery or radiotherapy. Choosing the most appropriate for each patient is a frequent source of controversy.

Material and methods

This paper includes an exhaustive literature review of issues related to VS that can serve as a clinical guide in the management of patients with these lesions. The presentation has been oriented in the form of questions that the clinician usually asks himself and the answers have been written and/or reviewed by a panel of national and international experts consulted by the Otology Commission of the SEORL-CCC.

Results

A list has been compiled containing the 13 most controversial thematic blocks on the management of VS in the form of 50 questions, and answers to all of them have been sought through a systematic literature review (articles published on PubMed and Cochrane Library between 1992 and 2023 related to each thematic area). Thirty-three experts, led by the Otology Committee of SEORL-CCC, have analyzed and discussed all the answers. In Annex 1, 14 additional questions divided into 4 thematic areas can be found.

Conclusions

This clinical practice guideline on the management of VS offers agreed answers to the most common questions that are asked about this tumour. The absence of sufficient prospective studies means that the levels of evidence on the subject are generally medium or low. This fact increases the interest of this type of clinical practice guidelines prepared by experts.

简介前庭分裂瘤(VS)是小脑视角最常见的肿瘤。放射学检查的普及提高了对该肿瘤的诊断率。根据肿瘤的特征、症状和患者的年龄,提出了三种治疗策略:观察、手术或放疗。材料和方法:本文对与 VS 相关的问题进行了详尽的文献综述,可作为此类病变患者的临床治疗指南。本文以临床医生通常会提出的问题为导向,由 SEORL-CCC 耳科委员会咨询的国内外专家小组撰写和/或审阅了答案:通过系统的文献回顾(1992 年至 2023 年期间在 PubMed 和 Cochrane 图书馆上发表的与每个专题领域相关的文章),为所有这些问题寻找答案。由 SEORL-CCC 耳科委员会领导的 33 位专家对所有答案进行了分析和讨论。在附件 1 中,还列出了 14 个分为 4 个专题领域的附加问题:本临床实践指南为 VS 的治疗提供了关于该肿瘤最常见问题的一致答案。由于缺乏足够的前瞻性研究,因此该主题的证据水平一般为中等或较低。这一事实增加了人们对这类由专家编写的临床实践指南的兴趣。
{"title":"Clinical practice guideline on the management of vestibular schwannoma","authors":"Luis Lassaletta ,&nbsp;Leticia Acle Cervera ,&nbsp;Xabier Altuna ,&nbsp;Emilio Amilibia Cabeza ,&nbsp;Miguel Arístegui Ruiz ,&nbsp;Ángel Batuecas Caletrio ,&nbsp;Jesús Benítez del Rosario ,&nbsp;Rubén Cabanillas Farpón ,&nbsp;María Costales Marcos ,&nbsp;Pedro Escada ,&nbsp;Juan Manuel Espinosa-Sánchez ,&nbsp;Roberto García Leal ,&nbsp;Javier Gavilán ,&nbsp;Justo Gómez Martínez ,&nbsp;Rocío González-Aguado ,&nbsp;Victor Martinez-Glez ,&nbsp;Gloria Guerra Jiménez ,&nbsp;Alejandro Harguindey Antolí-Candela ,&nbsp;Borja J. Hernández García ,&nbsp;Cesar Orús Dotú ,&nbsp;José Manuel Morales Puebla","doi":"10.1016/j.otoeng.2023.10.005","DOIUrl":"10.1016/j.otoeng.2023.10.005","url":null,"abstract":"<div><h3>Introduction</h3><p>Vestibular schwannoma (VS) is the most common tumour of the cerebellopontine angle. The greater accessibility to radiological tests has increased its diagnosis. Taking into account the characteristics of the tumour, the symptoms and the age of the patient, three therapeutic strategies have been proposed: observation, surgery or radiotherapy. Choosing the most appropriate for each patient is a frequent source of controversy.</p></div><div><h3>Material and methods</h3><p>This paper includes an exhaustive literature review of issues related to VS that can serve as a clinical guide in the management of patients with these lesions. The presentation has been oriented in the form of questions that the clinician usually asks himself and the answers have been written and/or reviewed by a panel of national and international experts consulted by the Otology Commission of the SEORL-CCC.</p></div><div><h3>Results</h3><p>A list has been compiled containing the 13 most controversial thematic blocks on the management of VS in the form of 50 questions, and answers to all of them have been sought through a systematic literature review (articles published on PubMed and Cochrane Library between 1992 and 2023 related to each thematic area). Thirty-three experts, led by the Otology Committee of SEORL-CCC, have analyzed and discussed all the answers. In Annex 1, 14 additional questions divided into 4 thematic areas can be found.</p></div><div><h3>Conclusions</h3><p>This clinical practice guideline on the management of VS offers agreed answers to the most common questions that are asked about this tumour. The absence of sufficient prospective studies means that the levels of evidence on the subject are generally medium or low. This fact increases the interest of this type of clinical practice guidelines prepared by experts.</p></div>","PeriodicalId":93855,"journal":{"name":"Acta otorrinolaringologica espanola","volume":"75 2","pages":"Pages 108-128"},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139725265","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The role of allergic and nonallergic rhinitis on success of type 1 cartilage tympanoplasty 过敏性和非过敏性鼻炎对1型软骨鼓室成形术成功的影响。
Pub Date : 2024-03-01 DOI: 10.1016/j.otoeng.2023.10.001
Elif Ersoy Çallıoğlu , Kazım Bozdemir , Şadan Soyyiğit , Saliha Atalay , Bengi Arslan

Objective

To investigate the role of allergic rhinitis (AR) and non-allergic rhinitis (NAR) on success of type 1 cartilage tympanoplasty.

Methods

This prospective study was conducted on 60 patients who had type 1 cartilage tympanoplasty. The patients were divided into three groups as no-rhinitis (n = 28), NAR (n = 18) and AR (n = 14) groups, based on their symptoms, skin prick tests and/or serum specific IgE levels. AR and NAR groups were treated for their rhinitis symptoms both pre- and postoperatively. The patients were followed up for a minimum of 6 months and compared for graft success rates and audiological outcomes.

Results

Three study groups were similar for age, gender distributions and preoperative air-bone gaps (p = 0.780, p = 0.167 and p = 0.676, respectively). Postoperative graft perforation rate was 0% in no-rhinitis and AR groups while it was 16.7% in NAR group, with a significant difference among three groups (p = 0.034). The comparison of three study groups for change in the postoperative air bone gaps in comparison with preoperative air bone gaps did not yield any statistically significant result (p = 0.729).

Conclusion

Although AR does not result in failure of type 1 cartilage tympanoplasty in patients treated for rhinitis compared to the control group, NAR does. Pre- and postoperative treatment of patients for rhinitis and employment of cartilage graft may be the key factors for success of surgery in patients with AR. Further studies with a larger sample size are needed.

目的:探讨过敏性鼻炎和非过敏性鼻炎对1型软骨鼓室成形术成功率的影响。方法:对60例1型软骨鼓室成形术患者进行前瞻性研究。将患者分为无鼻炎组(n = 28),NAR(n = 18) 和AR(n = 14) 根据症状、皮肤点刺试验和/或血清特异性IgE水平。AR组和NAR组在术前和术后均对其鼻炎症状进行治疗。对患者进行了至少6个月的随访,并比较了移植物成功率和听力学结果。结果:三个研究组在年龄、性别分布和术前气骨间隙方面相似(p = 0.780,p = 0.167和p = 0.676)。无鼻炎组和AR组术后移植物穿孔率为0%,NAR组为16.7%,三组间差异有统计学意义(p = 0.034)。三个研究组的术后气骨间隙与术前气骨间隙的变化比较没有产生任何统计学上显著的结果(p = 0.729)。结论:尽管与对照组相比,AR不会导致鼻炎患者1型软骨鼓室成形术失败,但NAR确实会。鼻炎患者的术前和术后治疗以及软骨移植可能是AR患者手术成功的关键因素。需要进行更大样本量的进一步研究。
{"title":"The role of allergic and nonallergic rhinitis on success of type 1 cartilage tympanoplasty","authors":"Elif Ersoy Çallıoğlu ,&nbsp;Kazım Bozdemir ,&nbsp;Şadan Soyyiğit ,&nbsp;Saliha Atalay ,&nbsp;Bengi Arslan","doi":"10.1016/j.otoeng.2023.10.001","DOIUrl":"10.1016/j.otoeng.2023.10.001","url":null,"abstract":"<div><h3>Objective</h3><p>To investigate the role of allergic rhinitis<span> (AR) and non-allergic rhinitis (NAR) on success of type 1 cartilage tympanoplasty.</span></p></div><div><h3>Methods</h3><p>This prospective study was conducted on 60 patients who had type 1 cartilage tympanoplasty. The patients were divided into three groups as no-rhinitis (<em>n</em> = 28), NAR (<em>n</em> = 18) and AR (<em>n</em> = 14) groups, based on their symptoms, skin prick tests and/or serum specific IgE levels. AR and NAR groups were treated for their rhinitis symptoms both pre- and postoperatively. The patients were followed up for a minimum of 6 months and compared for graft success rates and audiological outcomes.</p></div><div><h3>Results</h3><p>Three study groups were similar for age, gender distributions and preoperative air-bone gaps (<em>p</em> = 0.780, <em>p</em> = 0.167 and <em>p</em> = 0.676, respectively). Postoperative graft perforation rate was 0% in no-rhinitis and AR groups while it was 16.7% in NAR group, with a significant difference among three groups (<em>p</em> = 0.034). The comparison of three study groups for change in the postoperative air bone gaps in comparison with preoperative air bone gaps did not yield any statistically significant result (<em>p</em> = 0.729).</p></div><div><h3>Conclusion</h3><p>Although AR does not result in failure of type 1 cartilage tympanoplasty in patients<span> treated for rhinitis compared to the control group, NAR does. Pre- and postoperative treatment of patients for rhinitis and employment of cartilage graft may be the key factors for success of surgery in patients with AR. Further studies with a larger sample size are needed.</span></p></div>","PeriodicalId":93855,"journal":{"name":"Acta otorrinolaringologica espanola","volume":"75 2","pages":"Pages 102-107"},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71429992","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Perichondritis and auricular cellulitis related to piercings as first manifestation of monkeypox 与穿孔有关的软骨周炎和耳廓蜂窝织炎是猴痘的首发症状。
Pub Date : 2024-03-01 DOI: 10.1016/j.otoeng.2024.01.001
Encarnación Antúnez-Estudillo , Laura Riera Tur , Andrés Caballero García

Introduction

Pinna infections are usually due to Staphylococcus aureus infection. It is common for the patient to have had an earring in the area of infection. Monkeypox infection has gone from being an endemic infection to a worldwide health emergency.

Case summary

In this article we present five cases of monkeypox earring infection of the pinna and what common features we have seen that differentiate them from Staphylococcus aureus infection.

Discussion

Symptoms of monkeypox include general malaise, fever with uni- or bilateral lymphadenopathy, and then the appearance within one or two days of skin lesions, we want to alert he otolaryngologist and the medical society to the possibility the diagnostic possibility of monkeypox in patients with an auricular perichondritis.

简介耳廓感染通常是由于金黄色葡萄球菌感染所致。患者通常在感染部位戴过耳环。病例摘要:本文介绍了五例猴痘耳环感染耳廓的病例,以及我们所见的区别于金黄色葡萄球菌感染的共同特征:猴痘的症状包括全身不适、发热并伴有单侧或双侧淋巴结肿大,然后在一到两天内出现皮损,我们希望提醒耳鼻喉科医生和医学会注意耳廓周软骨炎患者诊断猴痘的可能性。
{"title":"Perichondritis and auricular cellulitis related to piercings as first manifestation of monkeypox","authors":"Encarnación Antúnez-Estudillo ,&nbsp;Laura Riera Tur ,&nbsp;Andrés Caballero García","doi":"10.1016/j.otoeng.2024.01.001","DOIUrl":"10.1016/j.otoeng.2024.01.001","url":null,"abstract":"<div><h3>Introduction</h3><p>Pinna infections are usually due to <em>Staphylococcus aureus</em><span> infection. It is common for the patient to have had an earring in the area of infection. Monkeypox infection has gone from being an endemic infection to a worldwide health emergency.</span></p></div><div><h3>Case summary</h3><p>In this article we present five cases of monkeypox earring infection of the pinna and what common features we have seen that differentiate them from <em>Staphylococcus aureus</em> infection.</p></div><div><h3>Discussion</h3><p><span>Symptoms of monkeypox include general malaise, fever with uni- or bilateral lymphadenopathy<span>, and then the appearance within one or two days of skin lesions, we want to alert he otolaryngologist and the medical society to the possibility the diagnostic possibility of monkeypox </span></span>in patients with an auricular perichondritis.</p></div>","PeriodicalId":93855,"journal":{"name":"Acta otorrinolaringologica espanola","volume":"75 2","pages":"Pages 129-132"},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139467472","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Genetic diagnosis of childhood sensorineural hearing loss 儿童感音神经性听力损失的基因诊断。
Pub Date : 2024-03-01 DOI: 10.1016/j.otoeng.2023.07.002
Sara Reda del Barrio , Alfredo García Fernández , Juan Francisco Quesada-Espinosa , María Teresa Sánchez-Calvín , Irene Gómez-Manjón , Olalla Sierra-Tomillo , Alexandra Juárez-Rufián , Joaquín de Vergas Gutiérrez

Introduction

Congenital/early-onset sensorineural hearing loss (SNHL) is one of the most common hereditary disorders in our environment. There is increasing awareness of the importance of an etiologic diagnosis, and genetic testing with next-generation sequencing (NGS) has the highest diagnostic yield. Our study shows the genetic results obtained in a cohort of patients with bilateral congenital/early-onset SNHL.

Materials and methods

We included 105 children with bilateral SNHL that received genetic testing between 2019 and 2022. Genetic tests were performed with whole exome sequencing, analyzing genes related to hearing loss (virtual panel with 244 genes).

Results

48% (50/105) of patients were genetically diagnosed. We identified pathogenic and likely pathogenic variants in 26 different genes, and the most frequently mutated genes were GJB2, USH2A and STRC. 52% (26/50) of variants identified produced non-syndromic hearing loss, 40% (20/50) produced syndromic hearing loss, and the resting 8% (4/50) could produce both non-syndromic and syndromic hearing loss.

Conclusions

Genetic testing plays a vital role in the etiologic diagnosis of bilateral SNHL. Our cohort shows that genetic testing with NGS has a high diagnostic yield and can provide useful information for the clinical workup of patients.

简介先天性/早发性感音神经性听力损失(SNHL)是我们生活环境中最常见的遗传性疾病之一。人们越来越意识到病因诊断的重要性,而下一代测序(NGS)基因检测具有最高的诊断率。我们的研究显示了一组双侧先天性/早发性 SNHL 患者的遗传结果:我们纳入了在2019年至2022年期间接受基因检测的105名患有双侧SNHL的儿童。基因检测采用全外显子组测序,分析与听力损失相关的基因(虚拟面板,包含 244 个基因):48%(50/105)的患者得到了基因诊断。我们在 26 个不同的基因中发现了致病和可能致病的变异,最常见的变异基因是 GJB2、USH2A 和 STRC。52%的变异基因(26/50)会导致非综合征性听力损失,40%的变异基因(20/50)会导致综合征性听力损失,其余8%的变异基因(4/50)既会导致非综合征性听力损失,也会导致综合征性听力损失:结论:基因检测在双侧SNHL的病因诊断中起着至关重要的作用。结论:基因检测在双侧 SNHL 的病因诊断中起着至关重要的作用。我们的队列显示,使用 NGS 进行基因检测具有很高的诊断率,可为患者的临床工作提供有用的信息。
{"title":"Genetic diagnosis of childhood sensorineural hearing loss","authors":"Sara Reda del Barrio ,&nbsp;Alfredo García Fernández ,&nbsp;Juan Francisco Quesada-Espinosa ,&nbsp;María Teresa Sánchez-Calvín ,&nbsp;Irene Gómez-Manjón ,&nbsp;Olalla Sierra-Tomillo ,&nbsp;Alexandra Juárez-Rufián ,&nbsp;Joaquín de Vergas Gutiérrez","doi":"10.1016/j.otoeng.2023.07.002","DOIUrl":"10.1016/j.otoeng.2023.07.002","url":null,"abstract":"<div><h3>Introduction</h3><p>Congenital/early-onset sensorineural hearing loss (SNHL) is one of the most common hereditary disorders in our environment. There is increasing awareness of the importance of an etiologic diagnosis, and genetic testing with next-generation sequencing (NGS) has the highest diagnostic yield. Our study shows the genetic results obtained in a cohort of patients with bilateral congenital/early-onset SNHL.</p></div><div><h3>Materials and methods</h3><p>We included 105 children with bilateral SNHL that received genetic testing between 2019 and 2022. Genetic tests were performed with whole exome sequencing, analyzing genes related to hearing loss (virtual panel with 244 genes).</p></div><div><h3>Results</h3><p>48% (50/105) of patients were genetically diagnosed. We identified pathogenic and likely pathogenic variants in 26 different genes, and the most frequently mutated genes were <em>GJB2</em>, <em>USH2A</em> and <em>STRC</em>. 52% (26/50) of variants identified produced non-syndromic hearing loss, 40% (20/50) produced syndromic hearing loss, and the resting 8% (4/50) could produce both non-syndromic and syndromic hearing loss.</p></div><div><h3>Conclusions</h3><p>Genetic testing plays a vital role in the etiologic diagnosis of bilateral SNHL. Our cohort shows that genetic testing with NGS has a high diagnostic yield and can provide useful information for the clinical workup of patients.</p></div>","PeriodicalId":93855,"journal":{"name":"Acta otorrinolaringologica espanola","volume":"75 2","pages":"Pages 83-93"},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139473176","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prognostic capacity of PIV (pan-immune-inflammation value) in patients with head and neck squamous cell carcinoma 头颈部鳞状细胞癌患者的 PIV(泛免疫炎症值)预后能力。
Pub Date : 2024-03-01 DOI: 10.1016/j.otoeng.2023.07.003
Aina Sansa , Cristina Valero , Albert Pujol , Blanca Sauter , Julia Gayà , Miquel Quer , Xavier León

Introduction

The pan-immune-inflammation value (PIV), an index that results from the following ratio: (neutrophils × monocytes × platelets)/lymphocytes, has been proposed as a prognostic biomarker in different tumour models. The aim of this study is to analyse the prognostic capacity of PIV in patients with head and neck squamous cell carcinoma (HNSCC).

Patients and methods

Retrospective study of 1187 patients with HNSCC treated at our centre between 2000−2017. PIV value was obtained from an analysis performed within 3 weeks prior to the start of treatment.

Results

PIV value was significantly associated with toxic consumption (0.001), tumour location (0.0001), tumour extension (0.0001), and histological grade (0.016). Four categories were defined based on PIV value using a recursive partitioning analysis: category I: PIV < 136.3 (n = 118, 9.9%), category II: PIV 136.3–451.1 (n = 594, 50.0%), category III: PIV 451.1−1,141.2 (n = 357, 30.1%), and category IV: PIV > 1141.2 (n = 118, 9.9%). A significant and ordered decrease in disease-specific survival was observed as the PIV category increased. This decrease in survival was independent of the type of treatment, tumour extension, or location of the primary tumour. The PIV category was and independent prognostic factor of disease-specific survival in a multivariable study.

Conclusions

PIV is a prognostic biomarker in patients with HNSCC.

简介泛免疫炎症值(PIV)是由以下比率得出的指数:(中性粒细胞×单核细胞×血小板)/淋巴细胞,已被提出作为不同肿瘤模型的预后生物标志物。本研究旨在分析PIV在头颈部鳞状细胞癌(HNSCC)患者中的预后能力:回顾性研究:2000-2017年间在本中心接受治疗的1 187例HNSCC患者。PIV值来自治疗开始前3周内进行的分析:PIV值与毒性消耗(0.001)、肿瘤位置(0.0001)、肿瘤扩展(0.0001)和组织学分级(0.016)明显相关。通过递归分区分析,根据 PIV 值定义了四个类别:类别 I:PIV 1,141.2 (n = 118,9.9%)。随着 PIV 类别的增加,疾病特异性生存率出现了明显的有序下降。生存率的下降与治疗类型、肿瘤扩展或原发肿瘤位置无关。在一项多变量研究中,PIV类别是疾病特异性生存率的独立预后因素:结论:PIV是HNSCC患者的预后生物标志物。
{"title":"Prognostic capacity of PIV (pan-immune-inflammation value) in patients with head and neck squamous cell carcinoma","authors":"Aina Sansa ,&nbsp;Cristina Valero ,&nbsp;Albert Pujol ,&nbsp;Blanca Sauter ,&nbsp;Julia Gayà ,&nbsp;Miquel Quer ,&nbsp;Xavier León","doi":"10.1016/j.otoeng.2023.07.003","DOIUrl":"10.1016/j.otoeng.2023.07.003","url":null,"abstract":"<div><h3>Introduction</h3><p><span>The pan-immune-inflammation value (PIV), an index that results from the following ratio: (neutrophils × monocytes × platelets)/lymphocytes, has been proposed as a prognostic biomarker in different tumour models. The aim of this study is to analyse the prognostic capacity of PIV </span>in patients<span> with head and neck squamous cell carcinoma (HNSCC).</span></p></div><div><h3>Patients and methods</h3><p>Retrospective study of 1187 patients with HNSCC treated at our centre between 2000−2017. PIV value was obtained from an analysis performed within 3 weeks prior to the start of treatment.</p></div><div><h3>Results</h3><p><span>PIV value was significantly associated with toxic consumption (0.001), tumour location (0.0001), tumour extension (0.0001), and histological grade (0.016). Four categories were defined based on PIV value using a recursive partitioning analysis: category I: PIV &lt; 136.3 (</span><em>n</em> = 118, 9.9%), category II: PIV 136.3–451.1 (<em>n</em> = 594, 50.0%), category III: PIV 451.1−1,141.2 (<em>n</em> = 357, 30.1%), and category IV: PIV &gt; 1141.2 (<em>n</em><span> = 118, 9.9%). A significant and ordered decrease in disease-specific survival was observed as the PIV category increased. This decrease in survival was independent of the type of treatment, tumour extension, or location of the primary tumour. The PIV category was and independent prognostic factor of disease-specific survival in a multivariable study.</span></p></div><div><h3>Conclusions</h3><p>PIV is a prognostic biomarker in patients with HNSCC.</p></div>","PeriodicalId":93855,"journal":{"name":"Acta otorrinolaringologica espanola","volume":"75 2","pages":"Pages 94-101"},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139467479","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tracheotomy versus tracheostomy, the need for lexicographical clarification 气管切开术与气管造口术,词汇学澄清的必要性。
Pub Date : 2024-03-01 DOI: 10.1016/j.otoeng.2023.06.011
Serafín Sánchez-Gómez , Elena Molina-Fernández , María Eugenia Acosta Mosquera , José María Palacios-García , Fernando López-Álvarez , María Sonia de Juana Morrondo , Beatriz Tena-García

In the healthcare field, the terms “traqueotomía” and “traqueostomía” are frequently used, often leading to confusion among professionals regarding the appropriate definition for each term or which one should be considered more correct in specific cases. A search was conducted for the terms “traqueotomía” and “traqueostomía” in general Spanish-language dictionaries such as the Dictionary of the Royal Spanish Academy (DRAE) and the Historical Dictionary of the Spanish Language of the Royal Spanish Academy (DHLE), as well as for the English terms “tracheotomy” and “tracheostomy” in English general dictionaries like the Oxford Dictionary, the Cambridge Dictionary, and the Collins English Dictionary. Additionally, searches were performed in medical dictionaries in both Spanish, specifically the Dictionary of Medical Terms of the National Academy of Medicine (DTM), and English, including the Farlex Dictionary. The terms were also explored using the Google search engine. Definitions were analyzed from both lexicographical and etymological perspectives. Definitions found in general dictionaries, in both Spanish and English, were found to be imprecise, limited, and ambiguous, as they mixed outdated indications with criteria that deviated from etymology. In contrast, definitions in medical dictionaries in both languages were more aligned with etymology. “Traqueotomía” strictly identifies the surgical procedure of creating an opening in the anterior face of the trachea. “Traqueostomía” identifies the creation of an opening that connects the trachea to the exterior, involving a modification of the upper airway by providing an additional entry for the respiratory pathway. “Traqueostomía” becomes the sole means of entry to the airway in total laryngectomies. Both terms can be used synonymously when a traqueotomía culminates in a traqueostomía. However, it is not appropriate to use the term “traqueostomía” when the procedure concludes with the closure of the planes and does not result in the creation of a stoma. Traqueostomas can be qualified with adjectives indicating permanence (temporary/permanent), size (large/small), shape (round/elliptical), or depth, without being linked to any specific disease or surgical indication. Not all permanent traqueostomas are the result of total laryngectomies, and they do not necessarily have an irreversible character systematically.

在医疗保健领域,"traqueotomía "和 "traqueostomía "这两个术语被频繁使用,常常导致专业人士对每个术语的适当定义或在特定情况下哪个术语更正确产生混淆。我们在《西班牙皇家学院词典》(DRAE)和《西班牙皇家学院西班牙语历史词典》(DHLE)等西班牙语词典中对 "traqueotomía "和 "traqueostomía "进行了检索,并在《牛津词典》、《剑桥词典》和《柯林斯英语词典》等英语词典中对 "tracheotomy "和 "tracheostomy "进行了检索。此外,还在西班牙语(特别是《美国国家医学院医学术语词典》(DTM))和英语(包括《Farlex 词典》)医学词典中进行了搜索。此外,还使用谷歌搜索引擎对这些术语进行了搜索。从词典学和词源学两个角度对定义进行了分析。在西班牙语和英语的普通字典中找到的定义被认为是不精确、有限和含糊的,因为它们混合了过时的指示和偏离词源学的标准。相比之下,这两种语言的医学词典中的定义更符合词源学。"气管切开术"(Traqueotomía)严格指在气管前方开一个口的外科手术。而 "Traqueostomía "指的是在气管与外部连接处开一个口,通过为呼吸通道提供一个额外的入口来改变上气道。在全喉切除术中,"Traqueostomía "成为进入气道的唯一途径。当喉头切开术(traqueotomía)最终导致喉头切开术(traqueostomía)时,这两个术语可作为同义词使用。不过,当手术以关闭平面而不是创建造口结束时,使用 "造口术 "一词并不恰当。乳头状瘤可以用形容词来修饰,如永久性(暂时性/永久性)、大小(大/小)、形状(圆形/椭圆形)或深度等,而与任何特定疾病或手术指征无关。并非所有的永久性蔓状骨瘤都是全喉切除术的结果,它们也不一定具有不可逆转的系统性特征。
{"title":"Tracheotomy versus tracheostomy, the need for lexicographical clarification","authors":"Serafín Sánchez-Gómez ,&nbsp;Elena Molina-Fernández ,&nbsp;María Eugenia Acosta Mosquera ,&nbsp;José María Palacios-García ,&nbsp;Fernando López-Álvarez ,&nbsp;María Sonia de Juana Morrondo ,&nbsp;Beatriz Tena-García","doi":"10.1016/j.otoeng.2023.06.011","DOIUrl":"10.1016/j.otoeng.2023.06.011","url":null,"abstract":"<div><p>In the healthcare field, the terms “traqueotomía” and “traqueostomía” are frequently used, often leading to confusion among professionals regarding the appropriate definition for each term or which one should be considered more correct in specific cases. A search was conducted for the terms “traqueotomía” and “traqueostomía” in general Spanish-language dictionaries such as the Dictionary of the Royal Spanish Academy (DRAE) and the Historical Dictionary of the Spanish Language of the Royal Spanish Academy (DHLE), as well as for the English terms “tracheotomy” and “tracheostomy” in English general dictionaries like the Oxford Dictionary, the Cambridge Dictionary, and the Collins English Dictionary. Additionally, searches were performed in medical dictionaries in both Spanish, specifically the Dictionary of Medical Terms of the National Academy of Medicine (DTM), and English, including the Farlex Dictionary. The terms were also explored using the Google search engine. Definitions were analyzed from both lexicographical and etymological perspectives. Definitions found in general dictionaries, in both Spanish and English, were found to be imprecise, limited, and ambiguous, as they mixed outdated indications with criteria that deviated from etymology. In contrast, definitions in medical dictionaries in both languages were more aligned with etymology. “Traqueotomía” strictly identifies the surgical procedure of creating an opening in the anterior face of the trachea. “Traqueostomía” identifies the creation of an opening that connects the trachea to the exterior, involving a modification of the upper airway by providing an additional entry for the respiratory pathway. “Traqueostomía” becomes the sole means of entry to the airway in total laryngectomies. Both terms can be used synonymously when a traqueotomía culminates in a traqueostomía. However, it is not appropriate to use the term “traqueostomía” when the procedure concludes with the closure of the planes and does not result in the creation of a stoma. Traqueostomas can be qualified with adjectives indicating permanence (temporary/permanent), size (large/small), shape (round/elliptical), or depth, without being linked to any specific disease or surgical indication. Not all permanent traqueostomas are the result of total laryngectomies, and they do not necessarily have an irreversible character systematically.</p></div>","PeriodicalId":93855,"journal":{"name":"Acta otorrinolaringologica espanola","volume":"75 2","pages":"Pages 73-82"},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139473178","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
In response to the letter to the editor “Comments to: Manifestations ENT manifestations in monkeypox” 回应题为 "对猴痘耳鼻喉科表现的评论 "的致编辑信
Pub Date : 2024-03-01 DOI: 10.1016/j.otoeng.2023.10.008
Berta Alegre , Isabel Vilaseca
{"title":"In response to the letter to the editor “Comments to: Manifestations ENT manifestations in monkeypox”","authors":"Berta Alegre ,&nbsp;Isabel Vilaseca","doi":"10.1016/j.otoeng.2023.10.008","DOIUrl":"10.1016/j.otoeng.2023.10.008","url":null,"abstract":"","PeriodicalId":93855,"journal":{"name":"Acta otorrinolaringologica espanola","volume":"75 2","pages":"Page 135"},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139827586","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The effect of interleukin-33 expression on prognosis in patients with nasopharyngeal carcinoma. 白细胞介素-33的表达对鼻咽癌患者预后的影响
Pub Date : 2024-02-24 DOI: 10.1016/j.otoeng.2024.01.011
İbrahim Arslan, Hatice Yılmazçoban, Hülya Eyigör, Canan Sadullahoğlu, Derya Salim Kıvrak, Gözde Akgün, Ömer Tarık Selçuk

Introduction: Interleukin-33 (IL-33) is a newly defined inflammatory cytokine that is a member of the interleukin-1 (IL-1) gene family. This cytokine is expressed in structural cells, such as the vascular endothelium, bronchial epithelial cells, keratinocytes, epithelial cells of the stomach, and fibroblastic reticular cells of lymphoid tissues. Several studies suggest that IL-33 plays a role in head-and-neck cancer. The aim of this study was to retrospectively examine IL-33 expression in nasopharyngeal carcinoma (NPC) and to evaluate its relationship between clinicopathological characteristics and prognosis.

Methods: In this monocentric, retrospective analysis, the data of 43 cases diagnosed with primary NPC and 20 cases with normal nasopharyngeal tissue (diagnosed between 2014 and 2020) were evaluated regarding the relationship between the immunohistochemically analyzed IL-33 expression status and corresponding clinicopathological parameters.

Results: The mean age was 56.9 years. The majority (67.4%) of the patients had an early tumor stage (T1-T2). IL-33 expression was positive in 56% of the cases. The five-year overall survival rate was 77% for all patients, 90% for the patients with positive IL-33 expression, and 55% for those without IL-33 expression (p = 0.008, univariate analysis). In multivariate analysis, IL-33 expression was shown to be the only independent prognostic marker for nasopharyngeal carcinoma (p = 0.014).

Conclusion: This retrospective study showed that IL-33 expression could be considered an independent factor affecting positively prognosis in NPC.

简介白细胞介素-33(IL-33)是一种新定义的炎症细胞因子,是白细胞介素-1(IL-1)基因家族的成员。这种细胞因子在结构细胞中表达,如血管内皮细胞、支气管上皮细胞、角质形成细胞、胃上皮细胞和淋巴组织的成纤维网细胞。多项研究表明,IL-33 在头颈癌中发挥作用。本研究旨在回顾性检测鼻咽癌(NPC)中 IL-33 的表达,并评估其与临床病理特征和预后之间的关系:在这项单中心回顾性分析中,对43例确诊为原发性鼻咽癌的病例和20例正常鼻咽组织病例(确诊时间为2014年至2020年)的数据进行了评估,以了解免疫组化分析的IL-33表达状态与相应临床病理参数之间的关系:平均年龄为 56.9 岁。大多数患者(67.4%)处于肿瘤早期(T1-T2)。56%的病例 IL-33 表达阳性。所有患者的五年总生存率为 77%,IL-33 表达阳性患者的五年总生存率为 90%,无 IL-33 表达患者的五年总生存率为 55%(单变量分析,P = 0.008)。多变量分析显示,IL-33表达是鼻咽癌唯一独立的预后标志物(p = 0.014):这项回顾性研究表明,IL-33的表达可被视为对鼻咽癌预后有积极影响的独立因素。
{"title":"The effect of interleukin-33 expression on prognosis in patients with nasopharyngeal carcinoma.","authors":"İbrahim Arslan, Hatice Yılmazçoban, Hülya Eyigör, Canan Sadullahoğlu, Derya Salim Kıvrak, Gözde Akgün, Ömer Tarık Selçuk","doi":"10.1016/j.otoeng.2024.01.011","DOIUrl":"10.1016/j.otoeng.2024.01.011","url":null,"abstract":"<p><strong>Introduction: </strong>Interleukin-33 (IL-33) is a newly defined inflammatory cytokine that is a member of the interleukin-1 (IL-1) gene family. This cytokine is expressed in structural cells, such as the vascular endothelium, bronchial epithelial cells, keratinocytes, epithelial cells of the stomach, and fibroblastic reticular cells of lymphoid tissues. Several studies suggest that IL-33 plays a role in head-and-neck cancer. The aim of this study was to retrospectively examine IL-33 expression in nasopharyngeal carcinoma (NPC) and to evaluate its relationship between clinicopathological characteristics and prognosis.</p><p><strong>Methods: </strong>In this monocentric, retrospective analysis, the data of 43 cases diagnosed with primary NPC and 20 cases with normal nasopharyngeal tissue (diagnosed between 2014 and 2020) were evaluated regarding the relationship between the immunohistochemically analyzed IL-33 expression status and corresponding clinicopathological parameters.</p><p><strong>Results: </strong>The mean age was 56.9 years. The majority (67.4%) of the patients had an early tumor stage (T1-T2). IL-33 expression was positive in 56% of the cases. The five-year overall survival rate was 77% for all patients, 90% for the patients with positive IL-33 expression, and 55% for those without IL-33 expression (p = 0.008, univariate analysis). In multivariate analysis, IL-33 expression was shown to be the only independent prognostic marker for nasopharyngeal carcinoma (p = 0.014).</p><p><strong>Conclusion: </strong>This retrospective study showed that IL-33 expression could be considered an independent factor affecting positively prognosis in NPC.</p>","PeriodicalId":93855,"journal":{"name":"Acta otorrinolaringologica espanola","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139975500","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Otorhinolaryngological manifestations in monkeypox: Comment 猴痘的耳鼻喉科表现:评论
Pub Date : 2024-01-01 DOI: 10.1016/j.otoeng.2023.06.010
Amnuay Kleebayoon , Viroj Wiwanitkit
{"title":"Otorhinolaryngological manifestations in monkeypox: Comment","authors":"Amnuay Kleebayoon ,&nbsp;Viroj Wiwanitkit","doi":"10.1016/j.otoeng.2023.06.010","DOIUrl":"10.1016/j.otoeng.2023.06.010","url":null,"abstract":"","PeriodicalId":93855,"journal":{"name":"Acta otorrinolaringologica espanola","volume":"75 1","pages":"Pages 70-71"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10311180","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Endoscopic ablation for glottic cancer in a patient with temporomandibular joint ankylosis 一例颞下颌关节强直患者的癌症声门内窥镜消融术。
Pub Date : 2024-01-01 DOI: 10.1016/j.otoeng.2023.09.003
Petru Gurău , Eusebiu Sencu , Sergiu Vetricean
{"title":"Endoscopic ablation for glottic cancer in a patient with temporomandibular joint ankylosis","authors":"Petru Gurău ,&nbsp;Eusebiu Sencu ,&nbsp;Sergiu Vetricean","doi":"10.1016/j.otoeng.2023.09.003","DOIUrl":"10.1016/j.otoeng.2023.09.003","url":null,"abstract":"","PeriodicalId":93855,"journal":{"name":"Acta otorrinolaringologica espanola","volume":"75 1","pages":"Pages 67-69"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10311182","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Acta otorrinolaringologica espanola
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1